BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Lidoflazine

Lidoflazine Coronary vasodilator with some antiarrhythmic action.

278+ PubMed studies analyzed · 17 RCTs · Evidence Score: 46.1

Research Domains

Lidoflazine has been studied across 18 research domains including ❤️ Cardiovascular, 🦴 Bone & Joint, 🌤️ Mood & Depression, ⚡ Energy & Fatigue, 🫁 Respiratory. The primary research focus is ❤️ Cardiovascular with 37% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lidoflazine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

oxatomide
25 shared targets
Promethazine
27 shared targets
Meclizine
17 shared targets
protriptyline
16 shared targets
Melphalan
20 shared targets
Hydroxyzine
19 shared targets
dilazep
16 shared targets
Nortriptyline
27 shared targets
Maprotiline
25 shared targets
Cytarabine
15 shared targets
Loading evidence profile...

This evidence profile for Lidoflazine is generated deterministically from 278 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.